Clinical Research Support for the CCR

CCR 的临床研究支持

• 批准号: 10926679
• 负责人: thomas a misteli
• 金额: $ 588.55万
• 依托单位: DIVISION OF BASIC SCIENCES - NCI
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10926679
• 关键词: Biological Assay; CCR; Clinical; Clinical Research; Cryopreservation; Dedications; Development; Drug Kinetics; End Point Assay; Flow Cytometry; Genomics; HIV/AIDS; Human; Immunooncology; Laboratories; Malignant Neoplasms; Malignant lymphoid neoplasm; Malignant neoplasm of gastrointestinal tract; Malignant neoplasm of thorax; Molecular Biology; Operative Surgical Procedures; Patients; Pediatric Oncology; Research Support; Safety; Services; Therapeutic Agents; Urologic Oncology; Vaccines; carcinogenesis; clinical investigation; histotechnology; imaging program; molecular imaging; programs; specific biomarkers

Current major users of dedicated clinical laboratory service users include the following CCR Branches, Laboratories and Programs: Pediatric Oncology Branch (POB), Surgery Branch (SB), Lymphoid Malignancies Branch (LMB), Vaccine Branch (VB), HIV/AIDS Malignancy Branch (HAMB), Center for Immuno-Oncology (CIO), Urologic Oncology Branch (UOB), Thoracic and GI Malignancies Branch (TGMB), Molecular Imaging Program (MIP), Laboratory of Molecular Biology (LMB), and Laboratory of Human Carcinogenesis (LHC).

目前专用临床实验室服务用户的主要用户包括以下 CCR 分支机构、实验室和项目：儿科肿瘤科 (POB)、外科科 (SB)、淋巴恶性肿瘤科 (LMB)、疫苗科 (VB)、艾滋病毒/艾滋病恶性肿瘤科 (HAMB)、免疫肿瘤学中心 (CIO)、泌尿肿瘤科 (UOB)、胸部和胃肠道肿瘤科 恶性肿瘤分会 (TGMB)、分子影像项目 (MIP)、分子生物学实验室 (LMB) 和人类癌变实验室 (LHC)。